Phenotypic spectrum and transcriptomic profile associated with germline variants in TRAF7.


Journal

Genetics in medicine : official journal of the American College of Medical Genetics
ISSN: 1530-0366
Titre abrégé: Genet Med
Pays: United States
ID NLM: 9815831

Informations de publication

Date de publication:
07 2020
Historique:
received: 13 11 2019
accepted: 23 03 2020
revised: 22 03 2020
pubmed: 8 5 2020
medline: 28 4 2021
entrez: 8 5 2020
Statut: ppublish

Résumé

Somatic variants in tumor necrosis factor receptor-associated factor 7 (TRAF7) cause meningioma, while germline variants have recently been identified in seven patients with developmental delay and cardiac, facial, and digital anomalies. We aimed to define the clinical and mutational spectrum associated with TRAF7 germline variants in a large series of patients, and to determine the molecular effects of the variants through transcriptomic analysis of patient fibroblasts. We performed exome, targeted capture, and Sanger sequencing of patients with undiagnosed developmental disorders, in multiple independent diagnostic or research centers. Phenotypic and mutational comparisons were facilitated through data exchange platforms. Whole-transcriptome sequencing was performed on RNA from patient- and control-derived fibroblasts. We identified heterozygous missense variants in TRAF7 as the cause of a developmental delay-malformation syndrome in 45 patients. Major features include a recognizable facial gestalt (characterized in particular by blepharophimosis), short neck, pectus carinatum, digital deviations, and patent ductus arteriosus. Almost all variants occur in the WD40 repeats and most are recurrent. Several differentially expressed genes were identified in patient fibroblasts. We provide the first large-scale analysis of the clinical and mutational spectrum associated with the TRAF7 developmental syndrome, and we shed light on its molecular etiology through transcriptome studies.

Identifiants

pubmed: 32376980
doi: 10.1038/s41436-020-0792-7
pii: S1098-3600(21)01187-4
pmc: PMC8093014
mid: NIHMS1691645
doi:

Substances chimiques

TRAF7 protein, human 0
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1215-1226

Subventions

Organisme : NHGRI NIH HHS
ID : UM1 HG008900
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG009599
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR002541
Pays : United States
Organisme : NHGRI NIH HHS
ID : UM1 HG006542
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01HG009599
Pays : United States
Organisme : NICHD NIH HHS
ID : P50 HD103538
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01 HG009141
Pays : United States

Références

Zotti T, Scudiero I, Vito P, Stilo R. The emerging role of TRAF7 in tumor development. J Cell Physiol. 2017;232:1233–1238.
doi: 10.1002/jcp.25676
Bouwmeester T, Bauch A, Ruffner H, et al. A physical and functional map of the human TNF-alpha/NF-kappa B signal transduction pathway. Nat Cell Biol. 2004;6:97–105.
doi: 10.1038/ncb1086
Xu L-G, Li L-Y, Shu H-B. TRAF7 potentiates MEKK3-induced AP1 and CHOP activation and induces apoptosis. J Biol Chem. 2004;279:17278–17282.
doi: 10.1074/jbc.C400063200
Scudiero I, Zotti T, Ferravante A, et al. Tumor necrosis factor (TNF) receptor-associated factor 7 is required for TNFα-induced Jun NH2-terminal kinase activation and promotes cell death by regulating polyubiquitination and lysosomal degradation of c-FLIP protein. J Biol Chem. 2012;287:6053–6061.
doi: 10.1074/jbc.M111.300137
Tsikitis M, Acosta-Alvear D, Blais A, et al. Traf7, a MyoD1 transcriptional target, regulates nuclear factor-κB activity during myogenesis. EMBO Rep. 2010;11:969–976.
doi: 10.1038/embor.2010.154
Zotti T, Uva A, Ferravante A, et al. TRAF7 protein promotes Lys-29-linked polyubiquitination of IkappaB kinase (IKKgamma)/NF-kappaB essential modulator (NEMO) and p65/RelA protein and represses NF-kappaB activation. J Biol Chem. 2011;286:22924–22933.
doi: 10.1074/jbc.M110.215426
Wang L, Wang L, Zhang S, et al. Downregulation of ubiquitin E3 ligase TNF receptor-associated factor 7 leads to stabilization of p53 in breast cancer. Oncol Rep. 2013;29:283–287.
doi: 10.3892/or.2012.2121
Morita Y, Kanei-Ishii C, Nomura T, Ishii S. TRAF7 sequesters c-Myb to the cytoplasm by stimulating its sumoylation. Mol Biol Cell. 2005;16:5433–5444.
doi: 10.1091/mbc.e05-08-0731
Shirakura K, Ishiba R, Kashio T, et al. The Robo4-TRAF7 complex suppresses endothelial hyperpermeability in inflammation. J Cell Sci. 2019;132:jcs220228.
doi: 10.1242/jcs.220228
Clark VE, Erson-Omay EZ, Serin A, et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science. 2013;339:1077–1080.
doi: 10.1126/science.1233009
Clark VE, Harmancı AS, Bai H, et al. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas. Nat Genet. 2016;48:1253–1259.
doi: 10.1038/ng.3651
Reuss DE, Piro RM, Jones DTW, et al. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations. Acta Neuropathol. 2013;125:351–358.
doi: 10.1007/s00401-013-1093-x
Abedalthagafi M, Bi WL, Aizer AA, et al. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma. Neuro-oncology. 2016;18:649–655.
doi: 10.1093/neuonc/nov316
Bueno R, Stawiski EW, Goldstein LD, et al. Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations. Nat Genet. 2016;48:407–416.
doi: 10.1038/ng.3520
Klein CJ, Wu Y, Jentoft ME, et al. Genomic analysis reveals frequent TRAF7 mutations in intraneural perineuriomas. Ann Neurol. 2017;81:316–321.
doi: 10.1002/ana.24854
Goode B, Joseph NM, Stevers M, et al. Adenomatoid tumors of the male and female genital tract are defined by TRAF7 mutations that drive aberrant NF-kB pathway activation. Mod Pathol. 2018;31:660–673.
doi: 10.1038/modpathol.2017.153
Stevers M, Rabban JT, Garg K, et al. Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42. Mod Pathol. 2019;32:88–99.
doi: 10.1038/s41379-018-0127-2
Tokita MJ, Chen C-A, Chitayat D, et al. De novo missense variants in TRAF7 cause developmental delay, congenital anomalies, and dysmorphic features. Am J Hum Genet. 2018;103:154–162.
doi: 10.1016/j.ajhg.2018.06.005
Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–249.
doi: 10.1038/nmeth0410-248
Sobreira N, Schiettecatte F, Valle D, Hamosh A. GeneMatcher: a matching tool for connecting investigators with an interest in the same gene. Hum Mutat. 2015;36:928–930.
doi: 10.1002/humu.22844
Firth HV, Richards SM, Bevan AP, et al. DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet. 2009;84:524–533.
doi: 10.1016/j.ajhg.2009.03.010
Lessel D, Kubisch C. Hereditary syndromes with signs of premature aging. Dtsch Arztebl Int. 2019;116:489–496.
pubmed: 6726857 pmcid: 6726857
Verloes A, Bremond-Gignac D, Isidor B, et al. Blepharophimosis-mental retardation (BMR) syndromes: a proposed clinical classification of the so-called Ohdo syndrome, and delineation of two new BMR syndromes, one X-linked and one autosomal recessive. Am J Med Genet A. 2006;140:1285–1296.
doi: 10.1002/ajmg.a.31270
Li J, Ma J, Wang KS, et al. Baicalein inhibits TNF-α-induced NF-κB activation and expression of NF-κB-regulated target gene products. Oncol Rep. 2016;36:2771–2776.
doi: 10.3892/or.2016.5108
Sharpe HJ, Pau G, Dijkgraaf GJ, et al. Genomic analysis of smoothened inhibitor resistance in basal cell carcinoma. Cancer Cell. 2015;27:327–341.
doi: 10.1016/j.ccell.2015.02.001
Schapira M, Tyers M, Torrent M, Arrowsmith CH. WD40 repeat domain proteins: a novel target class? Nat Rev Drug Discov. 2017;16:773–786.
doi: 10.1038/nrd.2017.179
Yang J, Boerm M, McCarty M, et al. Mekk3 is essential for early embryonic cardiovascular development. Nat Genet. 2000;24:309–313.
doi: 10.1038/73550
Newbern J, Zhong J, Wickramasinghe RS, et al. Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development. Proc Natl Acad Sci USA. 2008;105:17115–17120.
doi: 10.1073/pnas.0805239105
Samuels IS, Karlo JC, Faruzzi AN, et al. Deletion of ERK2 mitogen-activated protein kinase identifies its key roles in cortical neurogenesis and cognitive function. J Neurosci. 2008;28:6983–6995.
doi: 10.1523/JNEUROSCI.0679-08.2008
Zhang Q, Lenardo MJ, Baltimore D. 30 years of NF-κB: a blossoming of relevance to human pathobiology. Cell. 2017;168:37–57.
doi: 10.1016/j.cell.2016.12.012
Sil AK, Maeda S, Sano Y, et al. IkappaB kinase-alpha acts in the epidermis to control skeletal and craniofacial morphogenesis. Nature. 2004;428:660–664.
doi: 10.1038/nature02421
Park YC, Burkitt V, Villa AR, et al. Structural basis for self-association and receptor recognition of human TRAF2. Nature. 1999;398:533–538.
doi: 10.1038/19110
Yoshida H, Jono H, Kai H, Li J-D. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. J Biol Chem. 2005;280:41111–41121.
doi: 10.1074/jbc.M509526200
Régnier CH, Masson R, Kedinger V, et al. Impaired neural tube closure, axial skeleton malformations, and tracheal ring disruption in TRAF4-deficient mice. Proc Natl Acad Sci U S A. 2002;99:5585–5590.
doi: 10.1073/pnas.052124799
Shiels H, Li X, Schumacker PT, et al. TRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungs. Am J Pathol. 2000;157:679–688.
doi: 10.1016/S0002-9440(10)64578-6

Auteurs

Laura Castilla-Vallmanya (L)

Department of Genetics, Microbiology and Statistics, Faculty of Biology, IBUB, Universitat de Barcelona; CIBERER, IRSJD, Barcelona, Spain.

Kaja K Selmer (KK)

Department of Research and Innovation, Division of Clinical Neuroscience, Oslo University Hospital and the University of Oslo, Oslo, Norway.
The National Center for Epilepsy, Oslo University Hospital, Oslo, Norway.

Clémantine Dimartino (C)

Laboratory of embryology and genetics of human malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Institut Imagine, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France.

Raquel Rabionet (R)

Department of Genetics, Microbiology and Statistics, Faculty of Biology, IBUB, Universitat de Barcelona; CIBERER, IRSJD, Barcelona, Spain.

Bernardo Blanco-Sánchez (B)

Laboratory of embryology and genetics of human malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Institut Imagine, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France.

Sandra Yang (S)

GeneDx, Gaithersburg, MD, USA.

Margot R F Reijnders (MRF)

Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.

Antonie J van Essen (AJ)

Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands.

Myriam Oufadem (M)

Laboratory of embryology and genetics of human malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Institut Imagine, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France.

Magnus D Vigeland (MD)

Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.
Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

Barbro Stadheim (B)

Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.

Gunnar Houge (G)

Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.

Helen Cox (H)

West Midlands Regional Genetics Service, Birmingham Women's NHS Foundation Trust, Birmingham Women's Hospital, Edgbaston, Birmingham, UK.

Helen Kingston (H)

Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Academic Health Sciences Centre, Manchester, UK.
Division of Evolution and Genomic Sciences, University of Manchester, School of Biological Sciences, Manchester, UK.

Jill Clayton-Smith (J)

Manchester Centre for Genomic Medicine, Central Manchester University Hospitals NHS Foundation Trust, Academic Health Sciences Centre, Manchester, UK.
Division of Evolution and Genomic Sciences, University of Manchester, School of Biological Sciences, Manchester, UK.

Jeffrey W Innis (JW)

Departments of Human Genetics, Pediatrics and Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

Maria Iascone (M)

Department of Pediatrics, ASST Papa Giovanni XXIII, Bergamo, Italy.

Anna Cereda (A)

Department of Pediatrics, ASST Papa Giovanni XXIII, Bergamo, Italy.

Sara Gabbiadini (S)

Department of Pediatrics, ASST Papa Giovanni XXIII, Bergamo, Italy.

Wendy K Chung (WK)

Departments of Pediatrics and Medicine, Columbia University Medical Center, New York, NY, USA.

Victoria Sanders (V)

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA.
Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Joel Charrow (J)

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA.

Emily Bryant (E)

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA.

John Millichap (J)

Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA.

Antonio Vitobello (A)

UF Innovation en diagnostic genomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.
INSERM UMR1231 GAD, Dijon, France.

Christel Thauvin (C)

UF Innovation en diagnostic genomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.
Centre de Reference maladies rares "Anomalies du Developpement et syndrome malformatifs" de l'Est, Centre de Genetique, Hopital d'Enfants, FHU TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

Frederic Tran Mau-Them (FT)

UF Innovation en diagnostic genomique des maladies rares, CHU Dijon Bourgogne, Dijon, France.
INSERM UMR1231 GAD, Dijon, France.

Laurence Faivre (L)

INSERM UMR1231 GAD, Dijon, France.
Centre de Reference maladies rares "Anomalies du Developpement et syndrome malformatifs" de l'Est, Centre de Genetique, Hopital d'Enfants, FHU TRANSLAD, CHU Dijon Bourgogne, Dijon, France.

Gaetan Lesca (G)

Department of Medical Genetics, Lyon Hospices Civils, Lyon, France.
Institut NeuroMyoGène, CNRS UMR 5310 - INSERM U1217, Université de Lyon, Lyon, France.

Audrey Labalme (A)

Department of Medical Genetics, Lyon Hospices Civils, Lyon, France.

Christelle Rougeot (C)

Hôpital Femme Mère Enfant, Service de Neuropédiatrie, Bron, France.

Nicolas Chatron (N)

Department of Medical Genetics, Lyon Hospices Civils, Lyon, France.
Institut NeuroMyoGène, CNRS UMR 5310 - INSERM U1217, Université de Lyon, Lyon, France.

Damien Sanlaville (D)

Department of Medical Genetics, Lyon Hospices Civils, Lyon, France.
Institut NeuroMyoGène, CNRS UMR 5310 - INSERM U1217, Université de Lyon, Lyon, France.

Katherine M Christensen (KM)

Saint Louis University School of Medicine, St. Louis, MO, USA.

Amelia Kirby (A)

Saint Louis University School of Medicine, St. Louis, MO, USA.

Raymond Lewandowski (R)

Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA.

Rachel Gannaway (R)

Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA.

Maha Aly (M)

Laboratory of embryology and genetics of human malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Institut Imagine, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France.

Anna Lehman (A)

Department of Medical Genetics, The University of British Columbia, Vancouver, BC, Canada.

Lorne Clarke (L)

Department of Medical Genetics, The University of British Columbia, Vancouver, BC, Canada.

Luitgard Graul-Neumann (L)

Institute of Human Genetics, Charité, Universitätsmedizin Berlin, Berlin, Germany.

Christiane Zweier (C)

Institute of Human Genetics, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.

Davor Lessel (D)

Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Bernarda Lozic (B)

Department of Pediatrics, University Hospital Centre Split; University of Split, School of medicine, Split, Croatia.

Ingvild Aukrust (I)

Department of Medical Genetics, Haukeland University Hospital, Bergen, Norway.

Ryan Peretz (R)

Driscoll Children's Hospital, Corpus Christi, TX, USA.

Robert Stratton (R)

Driscoll Children's Hospital, Corpus Christi, TX, USA.

Thomas Smol (T)

Institut de Génétique Médicale, CHU Lille, Lille, France.
Université de Lille, EA 7364 - RADEME - Maladies RAres du DEveloppement embryonnaire et du MEtabolisme, Lille, France.

Anne Dieux-Coëslier (A)

Institut de Génétique Médicale, CHU Lille, Lille, France.

Joanna Meira (J)

Division of Medical Genetics, University Hospital Professor Edgard Santos/ Federal University of Bahia (UFBA), Salvador, Bahia, Brazil.

Elizabeth Wohler (E)

McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD, USA.

Nara Sobreira (N)

McKusick-Nathans Department of Genetic Medicine, Johns Hopkins University, Baltimore, MD, USA.

Erin M Beaver (EM)

Mercy Kids Genetics, Mercy Children's Hospital, St. Louis, MO, USA.

Jennifer Heeley (J)

Mercy Kids Genetics, Mercy Children's Hospital, St. Louis, MO, USA.

Lauren C Briere (LC)

Division of Medical Genetics & Metabolism, Massachusetts General Hospital for Children, Boston, MA, USA.

Frances A High (FA)

Division of Medical Genetics & Metabolism, Massachusetts General Hospital for Children, Boston, MA, USA.

David A Sweetser (DA)

Division of Medical Genetics & Metabolism, Massachusetts General Hospital for Children, Boston, MA, USA.

Melissa A Walker (MA)

Department of Pediatric Neurology, Massachusetts General Hospital for Children, Boston, MA, USA.

Catherine E Keegan (CE)

Departments of Human Genetics, Pediatrics and Internal Medicine, University of Michigan, Ann Arbor, MI, USA.

Parul Jayakar (P)

Division of Genetics and Metabolism, Nicklaus Children's Hospital, Miami, FL, USA.

Marwan Shinawi (M)

Department of Pediatrics, Division of Genetics and Genomic Medicine, Washington University School of Medicine, St. Louis, MO, USA.

Wilhelmina S Kerstjens-Frederikse (WS)

Department of Genetics, University Medical Center Groningen, Groningen, The Netherlands.

Dawn L Earl (DL)

Seattle Children's Hospital, Seattle, WA, USA.

Victoria M Siu (VM)

University of Western Ontario, London, ON, Canada.

Emma Reesor (E)

University of Western Ontario, London, ON, Canada.

Tony Yao (T)

University of Western Ontario, London, ON, Canada.

Robert A Hegele (RA)

University of Western Ontario, London, ON, Canada.

Olena M Vaske (OM)

Department of Molecular, Cell and Developmental Biology, University of California Santa Cruz, Santa Cruz, CA, USA.

Shannon Rego (S)

Institute for Human Genetics, University of California San Francisco, San Francisco, CA, USA.

Kevin A Shapiro (KA)

Cortica Healthcare, San Diego, CA, USA.

Brian Wong (B)

Cortica Healthcare, San Diego, CA, USA.

Michael J Gambello (MJ)

Department of Human Genetics, Division of Medical Genetics, Emory University School of Medicine, Atlanta, GA, USA.

Marie McDonald (M)

Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.

Danielle Karlowicz (D)

Division of Medical Genetics, Department of Pediatrics, Duke University Medical Center, Durham, NC, USA.

Roberto Colombo (R)

Faculty of Medicine, Catholic University, IRCCS Policlinico Gemelli, Rome, Italy.
Center for the Study of Rare Hereditary Diseases (CeSMER), Niguarda Ca' Granda Metropolitan Hospital, Milan, Italy.

Alessandro Serretti (A)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Lynn Pais (L)

Broad Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.

Anne O'Donnell-Luria (A)

Broad Center for Mendelian Genomics, Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA.

Alison Wray (A)

Royal Children's Hospital, Melbourne, Australia.

Simon Sadedin (S)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia.

Belinda Chong (B)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia.

Tiong Y Tan (TY)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Australia.

John Christodoulou (J)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Australia.

Susan M White (SM)

Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Australia.
Department of Paediatrics, University of Melbourne, Melbourne, Australia.

Anne Slavotinek (A)

Department of Pediatrics, University of California San Francisco, San Francisco, CA, USA.

Deborah Barbouth (D)

Dr John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, FL, USA.

Dayna Morel Swols (D)

Dr John T. Macdonald Foundation Department of Human Genetics, University of Miami, Miller School of Medicine, Miami, FL, USA.

Mélanie Parisot (M)

Genomics Core Facility, Institut Imagine-Structure Fédérative de Recherche Necker INSERM UMR1163, Paris, France.
INSERM US24/CNRS UMS3633, Paris Descartes-Sorbonne Paris Cité University, Paris, France.

Christine Bole-Feysot (C)

Genomics Core Facility, Institut Imagine-Structure Fédérative de Recherche Necker INSERM UMR1163, Paris, France.
INSERM US24/CNRS UMS3633, Paris Descartes-Sorbonne Paris Cité University, Paris, France.

Patrick Nitschké (P)

Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France.
Bioinformatics Platform, INSERM UMR 1163, Institut Imagine, Paris, France.

Véronique Pingault (V)

Laboratory of embryology and genetics of human malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Institut Imagine, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France.
Département de Génétique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France.

Arnold Munnich (A)

Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France.
Département de Génétique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France.

Megan T Cho (MT)

GeneDx, Gaithersburg, MD, USA.

Valérie Cormier-Daire (V)

Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France.
Département de Génétique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France.
Laboratory of Molecular and Physiopathological Bases of Osteochondrodysplasia, INSERM UMR 1163, Institut Imagine, Paris, France.

Susanna Balcells (S)

Department of Genetics, Microbiology and Statistics, Faculty of Biology, IBUB, Universitat de Barcelona; CIBERER, IRSJD, Barcelona, Spain.

Stanislas Lyonnet (S)

Laboratory of embryology and genetics of human malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Institut Imagine, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France.
Département de Génétique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France.

Daniel Grinberg (D)

Department of Genetics, Microbiology and Statistics, Faculty of Biology, IBUB, Universitat de Barcelona; CIBERER, IRSJD, Barcelona, Spain.

Jeanne Amiel (J)

Laboratory of embryology and genetics of human malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Institut Imagine, Paris, France.
Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France.
Département de Génétique, Hôpital Necker-Enfants Malades, Assistance Publique Hôpitaux de Paris, Paris, France.

Roser Urreizti (R)

Department of Genetics, Microbiology and Statistics, Faculty of Biology, IBUB, Universitat de Barcelona; CIBERER, IRSJD, Barcelona, Spain.

Christopher T Gordon (CT)

Laboratory of embryology and genetics of human malformations, Institut National de la Santé et de la Recherche Médicale (INSERM) UMR 1163, Institut Imagine, Paris, France. chris.gordon@inserm.fr.
Paris Descartes-Sorbonne Paris Cité University, Institut Imagine, Paris, France. chris.gordon@inserm.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH